Abstract
A novel machine learning approach predicts the impact of tumor mutations on cellular phenotypes, overcomes limited training data, minimizes costly functional validation, and advances efforts to implement cancer precision medicine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have